To further elucidate the potential mechanisms underlying the anti-inflammatory effects of FGF1 (Fig. 3A), we examined whether FGF1 pretreatment could suppress NF-κB activation in LPS-induced ALI at 12 h. This evidence concerns the gene FGF1 and acute respiratory distress syndrome.